Compounds > epirubicin
Page last updated: 2024-08-23

epirubicin and Cell Transformation, Neoplastic

epirubicin has been researched along with Cell Transformation, Neoplastic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, J; Cornelissen, JJLM; Gu, W; Meng, F; Meng, H; Xu, Y; Yu, N; Zhong, Y; Zhong, Z1
Berry, FB; Buckley, NE; Crawford, NT; Gorski, JJ; Harkin, DP; Kennedy, RD; Mullan, PB; Tkocz, D1
Cobellis, L; Di Re, E; Grosso, G; Quattrone, P; Raspagliesi, F1

Other Studies

3 other study(ies) available for epirubicin and Cell Transformation, Neoplastic

ArticleYear
CD44-Specific A6 Short Peptide Boosts Targetability and Anticancer Efficacy of Polymersomal Epirubicin to Orthotopic Human Multiple Myeloma.
    Advanced materials (Deerfield Beach, Fla.), 2019, Volume: 31, Issue:46

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Synergism; Epirubicin; Humans; Hyaluronan Receptors; Mice; Molecular Targeted Therapy; Multiple Myeloma; Peptide Fragments; Urokinase-Type Plasminogen Activator

2019
BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers.
    Oncogene, 2012, Aug-09, Volume: 31, Issue:32

    Topics: Antineoplastic Agents; Base Sequence; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; Epirubicin; Epithelial-Mesenchymal Transition; Female; Fluorouracil; Forkhead Transcription Factors; GATA3 Transcription Factor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Inhibitory Concentration 50; Mitomycin; Molecular Sequence Data; Neoplasms, Basal Cell; Phenotype; Promoter Regions, Genetic; Protein Binding; RNA Interference; Transcription, Genetic

2012
Malignant degeneration in leiomyomatosis peritonealis disseminata.
    Gynecologic oncology, 1996, Volume: 61, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Dacarbazine; Epirubicin; Female; Humans; Ifosfamide; Leiomyomatosis; Middle Aged; Peritoneal Neoplasms

1996